The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe
- 77 Downloads
Although the treatment of attention-deficit hyperactivity disorder in adolescents brings new challenges, stimulant and nonstimulant medications are likely to be as effective in adolescents as they are in younger children. To ensure coverage of school and extracurricular activities, the use of longer-acting formulations is often required. The risk of adverse effects appears to be outweighed by the benefits of treatment.
ADHD less prevalent in adolescents …
Attention-deficit hyperactivity disorder (ADHD) has a declining prevalence from childhood to adolescence, although diagnostic criteria may result in the underestimation of its prevalence in adolescents. Although these criteria are sensitive to symptoms in younger children, they may not capture some of the symptoms present in adolescents with persistent ADHD. Problems relating to inattention, rather than to hyperactivity or impulsivity, are those that generally persist into adolescence. Therefore, even if diagnostic...
- 2.Hazell P. Pharmacological management of attention-deficit hyperactivity disorder in adolescents: special considerations. CNS Drugs 2007; 21 (1) 37-46Google Scholar
- 3.British Medical Association and the Royal Pharmaceutical Society of Great Britian. British national formulary. No. 53. London: BMJ Publishing Group Ltd and RPS Publishing, 2007 MarGoogle Scholar
- 4.WoltersKluwer Health Inc. Facts & comparisons 4.0 [online]. Available from URL: http://online.factsandcomparisons.com [Accessed 2007 Jun 20]
- 7.Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: technology appraisal 98. London: National Institute for Health and Clinical Excellence, 2006 MarGoogle Scholar
- 14.Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1999; 99(8): 979–82PubMedCrossRefGoogle Scholar
- 17.Institute for Clinical Systems Improvement. Health care guideline: diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. 7th ed. [online]. Available from URL: http://www.icsi.org [Accessed 2007 May 11]